PDL BioPharma Inc (NASDAQ:PDLI)

2.58
Delayed Data
As of Dec 04
 +0.04 / +1.57%
Today’s Change
1.86
Today|||52-Week Range
3.50
+5.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues585.1M242.5M320.1M198.1M
 
 
 
 
 
Cost of Goods Sold0.004.1M30.5M48.5M
 
 
 
 
Depreciation And Amortization--12.0M24.7M15.8M
 
 
 
 
 
Operating ExpensesGross Income585.1M226.4M264.8M133.8M
 
 
 
 
 
General Expenses36.1M44.1M70.7M65.5M
 
 
 
 
 
Other Operating Expenses4.0M0.000.000.00
 
 
Research And Development--3.8M7.4M3.0M
 
 
 
 
Total Operating Expenses40.1M60.2M125.9M129.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income545.0M182.2M194.1M68.3M
 
 
 
 
 
Extraordinary Credit6.5M3.7M0.0041.6M
 
 
 
 
Extraordinary Charge---60.7M-349.0K-160.5M
 
 
 
 
Interest Expense On Debt27.1M20.8M20.2M12.2M
 
 
 
 
 
Other Expenses5.8M4.9M11.0M6.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income530.1M109.4M184.5M-55.9M
 
 
 
 
 
Income Taxes-197.3M-45.7M-73.8M-12.9M
 
 
 
 
 
Minority Interest0.00-53.0K-47.0K0.00
 
 
 
Net Income332.8M63.6M110.7M-68.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS163.4M163.8M155.4M145.7M
 
 
 
 
 
Shares To Calculate EPS Diluted163.6M164.2M156.3M145.7M
 
 
 
 
 
 
Earnings Per ShareEPS$2.03$0.39$0.71-$0.47
 
 
 
 
 
EPS Diluted$2.03$0.39$0.71-$0.47